PSTX

Poseida Therapeutics (PSTX)

About Poseida Therapeutics (PSTX)

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.

Details

Daily high

$9.48

Daily low

$9.36

Price at open

$9.38

52 Week High

$9.58

52 Week Low

$1.87

Market cap

921.0M

Dividend yield

0.00%

Volume

2.1M

Avg. volume

2.9M

P/E ratio

-14.92

Poseida Therapeutics News